These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Is MRD eradication a desirable goal in CLL? Moreno C; Ritgen M; Rawstron A Best Pract Res Clin Haematol; 2010 Mar; 23(1):97-107. PubMed ID: 20620974 [TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime? Nabhan C; Coutré S; Hillmen P Br J Haematol; 2007 Feb; 136(3):379-92. PubMed ID: 17129223 [TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR. Ritgen M; Stilgenbauer S; von Neuhoff N; Humpe A; Brüggemann M; Pott C; Raff T; Kröber A; Bunjes D; Schlenk R; Schmitz N; Döhner H; Kneba M; Dreger P Blood; 2004 Oct; 104(8):2600-2. PubMed ID: 15205268 [TBL] [Abstract][Full Text] [Related]
20. Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia. Dreger P; Montserrat E Leukemia; 2002 Jun; 16(6):985-92. PubMed ID: 12040430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]